priority health glp-1 coverage Nutritional priorities to support GLP‐1 therapy for obesity: A joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society GLP-1 insurance coverage worsened at

The SELECT trial, published in 2023, enrolled 17,604 adults with overweight or obesity and established cardiovascular disease but without diabetes

GlutaMAX Skin Whitening Cream with its innovative blend of highest quality ingredients is designed for reducing blemishes and dark pigmentation

21 September 2020

This suggests that GLP-1 receptor agonists may confer cardiovascular protection through multiple mechanisms, potentially including anti-inflammatory effects, blood pressure reduction, and vascular benefits, in addition to lipid improvements

Cosmetic Science, 31(5): 327345

For clinicians, the trial could inform new care pathways involving baseline DEXA, mobility assessments, and long-term monitoring